IDBS Acquires InforSense to Provide End-to-End Solutions for Research & Development Data Management

06-30-2009: IDBS announced that it has concluded an unconditional agreement to acquire InforSense Ltd, a company providing scientific and business intelligence (BI) technologies, in an all-cash transaction. The acquisition will complete in July.

With the addition of the InforSense product portfolio, IDBS will expand its large scale data integration activities to support international data sharing and broaden its life sciences portfolio into the emerging growth area of biomarker development and personalized medicine. The InforSense brand, its products and partnerships will continue to be vigorously developed, marketed and supported around the world.

InforSense is a private company with offices in London (UK), Boston (USA) and Shanghai (PRC), and was founded in 1999 to develop and commercialize technology in the fields of high performance computing, and large scale data mining, originally developed at Imperial College, London. InforSense’s core expertise lies in the development of high performance business and scientific intelligence and in web-based reporting applications that are highly differentiated from standard BI tools by their capacity, rapid implementation and configurability. InforSense applications provide the framework for integrating data from an extremely broad range of data sources, for many multinational organizations from pharmaceuticals to finance. InforSense has also developed state of the art applications to integrate genomics, biomarker and clinical data, that provide a unique offering to researchers in the developing areas of translational and personalized medicine. InforSense’s founder, Professor Yike Guo will take up the role of Chief Innovation Officer at IDBS.